Neurotrophic Keratopathy Completed Phase 4 Trials for Cenegermin (DB13926)
Also known as: Neurotrophic Keratitis / Neurotrophic keratitis (disorder)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0077055 (Neurotrophic Keratopathy) | Completed | 4 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT04485546 | Study to Evaluate OXERVATE™ in Patients With Stage 1 Neurotrophic Keratitis | Treatment |